PubMed Health⌕ Search

PubMed · 3277303

Infection in the compromised host.

Abstract

In spite of the development of successive generations of more powerful antibiotics, sepsis remains a common cause of death in the surgical patient. This fact is not surprising, since it is of little importance which organism is causing the infection if the patient's intrinsic antibacterial defenses cannot respond. Realization of the limitations of antibiotic therapy has prompted many investigators to study the immune and inflammatory systems with the ultimate goal of improving host defenses and increasing survival. In this article the local and systemic antibacterial defense systems have been reviewed. It is clear that the immunocompromised state is associated with multiple defects of the humoral and cellular components of both the nonspecific host defense system and the specific immune defense system. However, although consensus has not been reached on either the mediators responsible for the immunocompromised state or the prognostic and clinical significance of many of the described defects, work in this field is progressing rapidly. Nonetheless, knowledge that the host's antibacterial defense systems can be aided by good surgical technique, nutrition, appropriate use of antibiotics, and the sterile care of invasive catheters, lines, and tubes is critical in the prevention of fatal infections in the immunocompromised patient. When more information becomes available concerning the complex interrelations between the various cellular and humoral components of the host defense systems and their mediators and the symbiotic relations between man and his bacterial flora, it should be possible to develop specific strategies for the clinician to use to reduce the risk of infection in the high-risk surgical patient. Thus, in the future it may not be unusual for the clinician to alter the immunologic system of the host by the use of immunomodulators or vaccines to increase the host's resistance to infection. On the other hand, by manipulating the complex interrelations between the host and the indigenous bacterial flora, it may be possible to prevent the development of opportunistic infections originating from the gastrointestinal tract.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E A Deitch. 1988. Infection in the compromised host.. https://doi.org/10.1016/s0039-6109(16)44439-7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Analysis of HLA class I specific antibodies in patients with failed allografts.

BACKGROUND: The goals of this study are first to determine the epitope specificity of donor specific antibody (DSA) in the serum of alloimmunized transplant patients with a failed renal graft; and second to understand the correlation between the development of DSA and nondonor specific antibody (NDSA). METHODS: The sera of 35 pretransplant panel reactive antibody (PRA)-negative patients with failed allografts were examined with single-antigen (SA) luminex beads to identify human leukocyte antigen (HLA)-A and -B antibodies. Potential HLA antibody epitopes were identified by using computer software and verified by absorption and elution from single-antigen cell lines. RESULTS: Twenty-seven patients developed donor-specific HLA-A and/or -B antibodies, while the remaining eight patients had only nondonor-specific HLA-A and/or -B antibodies. The DSA-positive patients also had a long list of NDSA. Sixty-eight percent of the reactions found in 27 recipients with DSA were attributable to 66 epitopes on the mismatched donor HLA molecule. All 39 NDSA in eight patients with only NDSA shared 17 epitopes within positive allele specificities. By absorption and elution using recombinant cell lines having a single HLA specificity, we confirmed the epitopes involved in three patients. CONCLUSION: Development of most NDSA in patients with failed allografts is likely due to sharing epitopes with DSA and/or other NDSA.

Antibody Formation↗

Human keratinocyte Toll-like receptors promote distinct immune responses.

It has been well established that Toll-like receptors (TLRs) are expressed by keratinocytes and respond to their respective ligands to initiate immune responses. However, it appears that keratinocytes, via differential activation of TLRs, may play a key role in determining the type of subsequent cutaneous immune response generated against a particular pathogen.

Antibody Formation↗